MIT’s new ‘recursive’ framework lets LLMs process 10 million tokens without context rot

While standard models suffer from context rot as data grows, MIT’s new Recursive Language Model (RLM) framework treats ...
The Motley Fool

Down 57% in 2024, Is Recursion Pharmaceuticals a Buy on the Dip?

Recursion Pharmaceuticals is a TechBio company trying to apply artificial intelligence (AI) to the new drug-discovery process. The first placebo-controlled trial results from Recursion Pharmaceuticals ...
Seeking Alpha

Recursion Pharmaceuticals: More Of A TechBio Industrializing Drug Discovery

This thesis makes the case for an investment in Recursion Pharmaceuticals operating as a TechBio which "industrializes" the process of drug discovery in contrast to a typical biotech. The difference ...
Seeking Alpha

Recursion Pharmaceuticals: Unprecedented Scale

Recursion Pharmaceuticals is an AI-enabled drug discovery company, differentiated by its scale and focus on understanding biology. The company has a broad pipeline across various therapeutic areas and ...

2 AI stocks to buy in 2026, and 1 to avoid

Some AI-focused companies are not worth the trouble.
JSTOR Daily

The Recursive Process In and Of Critical Literacy: Action Research in an Urban Elementary School

Canadian Journal of Education / Revue canadienne de l'éducation, Vol. 35, No. 2 (2012), pp. 41-57 (17 pages) Abstract This paper provides an overview of the recursive process of initiating an action ...